Company Filing History:
1 out of 1,013 
1 out of 6 
1 out of 780 Years Active: 2002-2009
Title: The Innovations of Christopher J. Stenland
Introduction
Christopher J. Stenland is an accomplished inventor based in Cary, North Carolina. With a strong background in biochemistry and a focus on therapeutic processes, he has made significant contributions to the field of plasmagen research. Stenland holds three patents that showcase his expertise and innovative approaches to medical treatments.
Latest Patents
Stenland's latest patents demonstrate his commitment to advancing medical science. One notable invention is the "Process for the Production of a Reversibly Inactive Acidified Plasmin Composition." This patent discloses a method for producing a reversibly inactive acidified plasmin by activating plasminogen, alongside a process for purifying plasminogen. The resulting plasmin can be isolated and stored with a low pH-buffering capacity agent, which enhances its stability. This invention has potential applications in thrombolytic therapy, offering new avenues for effective treatment.
Another significant patent is related to the "Sanitization of Chromatographic Media." This patent introduces a method for sanitizing chromatographic media by contacting it with an acidic chaotropic agent at low temperature and low pH, effectively providing pathogen removal and viral inactivation.
Career Highlights
Throughout his career, Christopher J. Stenland has been associated with leading companies in the biopharmaceutical sector. He has notably worked with Bayer Corporation, where he utilized his expertise to contribute to innovative solutions, and Talecris Biotherapeutics, Inc., where he further honed his skills in therapeutic applications.
Collaborations
Collaboration has been an essential aspect of Stenland's career. He has had the opportunity to work alongside talented colleagues such as Marina N. Korneyeva and James Rebbeor. These partnerships have enriched his research and fostered a collaborative environment for innovation.
Conclusion
Christopher J. Stenland's contributions to the field of biomedical research through his patents highlight his role as a leading inventor. His focus on processes that enhance the stability and safety of therapeutic agents underscores the importance of innovation in medical treatments. As he continues to advance in his career, Stenland remains a key figure in the pursuit of effective and safe therapeutic solutions.